Furthermore, activation of relevant signaling networks, such as the Akt pathway, is present, perhaps pointing to a more generalized applicability for this model to studies like preclinical testing, despite its reliance on a genetic lesion not associated with the vast majority of gliomas. Here, AKT1 is linked to central nervous system cancer.